Send Orders for Reprints to reprints@benthamscience.net
Protein & Peptide Letters, 2014, 21, 153-158
153
Analgesic Effects of Huwentoxin-IV on Animal Models of Inflammatory and Neuropathic Pain
Yu Liu, Zhe Wu, Dongfang Tang, Xiaohong Xun, Lichao Liu, Xianlei Li, Dongsong Nie, Yang Xiang, Jianming Yi and Jizu Yi*
College of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yueyang, 414006, China
Abstract: Huwentoxin-IV (HWTX-IV), a peptide with 35 amino acid residues, was discovered in the venom of spider Ornithoctonus huwena. The peptide had an inhibitory effect on a tetrodotoxin-sensitive (TTX-S) sodium channel with highly sensitive to Nav1.7, an attractive target for pain release therapy. In this study we further demonstrated the analgesic effects of HWTX-IV using mouse and rat as an inflammatory pain model and/or a neuropathic pain models. In the both cases, the analgesic effects of the peptide were dose-dependent, and statistically significant. In the inflammatory model, 100 g/kg of HWTX-IV produced an efficient reversal of hyperalgesia up to 63.6% after injection of formalin in rats with the efficiency equivalent to that of morphine at 50 g/kg, and 200 g/kg of HWTX-IV produced protective effect up to 55.6% after injection of acetic acid with the efficiency equivalent to that of morphine at 100 g/kg. In the spinal nerve model, the peptide produced the longer and higher reversal effect on allodynia than Mexiletine. These results demonstrated that HWTX-IV released efficiently the acute inflammatory pain and chronic neuropathic pain in these animals, suggesting that HWTX-IV was a potential and efficient candidate for further clinical drug development against inflammatory and neuropathic pain.
Keywords: Analgesic, huwentoxin-IV, inflammatory pain, neurotoxin, neuropathic pain. INTRODUCTION
Huwentoxin-IV (HWTX-IV), a 35-residue peptide (ECLEI FKACN PSNDQ CCKSS KLVCS RKTRW CKYQI), was discovered in tarantula Ornithoctonus huwena venom. The peptide amidated at its C-terminal end has a high proportion of basic residues, and six cysteine residues that form three intra-molecular disulfide bonds (Cys2-Cys17, Cys9-Cys24 and Cys16-Cys31). These disulfide bonds are required for its inhibitory activity of the peptide [1, 2]. HWTX-IV inhibited the neuronal tetrodotoxin-sensitive (TTX-S) sodium channels in rat dorsal root ganglion (DRG) cells, including neuronal voltage-gated sodium channels (VGSCs) specifically on subtypes rNav1.2, rNav1.3, and hNav1.7, compared with muscle subtypes rNav1.4 and hNav1.5. Of the five VGSCs examined, hNav1.7 was the greatest sensitive to HWTX-IV [1, 3, 4].
Among nine identified genes, namely Nav1.1-1.9, which encode sodium channels, each subtype gene can be function-ally classified as either tetrodotoxin-sensitive (TTX-S) or TTX-resistant (TTX-R) [5]. Both in vivo and in vitro studies indicated that VGSCs played a key role in pain reduction, which began with the aberrant firing of bursts in damaged neuronal tissue [6, 7]. Pharmacological and genetic data have provided evidence for specific involvement of Nav1.3, 1.7, 1.8, and 1.9 in the processing of nociceptive information [7].
*Address correspondence to this author at the College of Chemistry and Chemical Engineering, Hunan Institute of Science and Technology, Yuey-ang, 414006, China; Tel: +86-730-8640122; Fax: +86-730-8640122; E-mail: jizu_yi@yahoo.com
- 5/14 $58.00+.00
Over the last decade, there has been considerable debate re-garding which sodium channel would provide the best target for the development of novel analgesics [8]. Compelling genetic evidence linking Nav1.7 to pain in human beings was also provided by the observations of gain or loss of its functions after mutations in SCN9A, the gene encoding Nav1.7 [9-11]. These studies provide strong genetic evidence for the importance of Nav1.7 in pain [8].
Many peptide toxins from spiders have been identified to be highly potential and selective blockers of sodium chan-nels [9]. Some of these peptides are highly valuable as phar-macological tools and leading compound for developing human disease drugs. As sodium channel blockers were ef-fective analgesics when delivered at low concentrations [10], the present investigations were intended to further character-ize the antinociceptive effects of HWTX-IV on mouse and/or rat models of inflammatory and neuropathic pain. The results indicated that HWTX-IV produced dose-dependent attenua-tion of tactile allodynia on the animal models of inflam-matory and neuropathic pain, and suggested that HWTX-IV was indeed an effective candidate for further drug develop-ment against inflammatory and neuropathic pain. MATERIALS AND METHODS Peptide
HWTX-IV was synthesized on an automatic peptide synthesizer (PerSeptive Biosystems, Boston, MA) using an Fmoc/tert-butyl strategy and HOBt/TBTU/NMM coupling method [2, 11]. All amino acids were purchased from Che-© 2014 Bentham Science Publishers
translational in the search for analgesic agents. ...animal models of inflammatory, diabetic, neuropathic...The therapeutic effects are most likely attributable...
The Analgesic Potency of... 暂无评价 8页 免费... Animal Models of Postope... 20页 1财富值 ... neuropathic pain and inflammatory pain, although ...
114 – 121 www.elsevier.com/locate/pharmbiochembeh Analgesic effects of ...tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. ...
Anti-inflammatory and ... 8页 免费 25...animal models of tumorigenesis,29–34 but so far...use as an analgesic, aspirin has been proven ...
In order to explore the anti-inflammatory and analgesic effects of “DANXIAN KANGGU” (Bone-strengthening, BS) capsules, animal models of acute and ...
Anti-inflammatory and ... 8页 免费 25...animal models of tumorigenesis,29–34 but so far...use as an analgesic, aspirin has been proven ...
热门文档